Some fistulas do heal without conventional open surgery, but the odds depend heavily on the type, location, and underlying cause. A simple enterocutaneous fistula that develops after abdominal surgery, for example, closes on its own roughly 60 percent of the time with conservative management alone. Perianal fistulas linked to Crohn’s disease respond to biologic medications in many patients, and newer options like stem cell injections have shown healing rates above 60 percent in pooled data. The landscape of non-surgical and minimally invasive approaches has expanded considerably, though not every fistula is a candidate for these strategies, and “non-surgical” sometimes still means a procedure room visit.
When Fistulas Close on Their Own
Spontaneous closure is more realistic for some fistulas than others. Enterocutaneous fistulas, the abnormal tunnels that connect the bowel to the skin surface after abdominal surgery or trauma, are among the best-studied examples. In a review of patients treated without an operation, about 60 percent achieved healing through nonoperative care alone.1PubMed. Enterocutaneous fistula: are treatments improving? That care typically involves controlling infection, managing the fluid draining from the fistula, and giving the bowel time to rest and repair.
Nutrition is a major piece of this puzzle. When a fistula drains heavily, you lose not just fluid but electrolytes, proteins, and calories at a rate that can quickly lead to malnutrition. Strict bowel rest combined with intravenous nutrition is often the starting point, especially for high-output fistulas draining more than 500 milliliters per day. As output drops and the fistula shows signs of settling, many patients can transition to eating by mouth or receiving tube feeding.2PubMed Central. Use of parenteral nutrition in the management of enterocutaneous fistula Early and adequate nutritional support has been shown to play a significant role in whether a fistula ultimately closes or requires surgery.3PubMed Central. Nutritional Management in Enterocutaneous Fistula. What is the evidence?
For vesicovaginal fistulas, which connect the bladder to the vagina, prolonged bladder drainage with a catheter alone has produced spontaneous closure in some cases. The reported success rates vary wildly, from 0 to 100 percent in different series, but the strongest predictor of success is how quickly drainage begins after the fistula forms. The longer a fistula tract sits open, the more its lining becomes covered in skin-like tissue that essentially seals the tunnel in its open state, blocking any chance of natural healing.4PubMed. Spontaneous closure of vesicovaginal fistulas after bladder drainage alone: review of the evidence
Biologic Medications for Crohn’s-Related Fistulas
Perianal fistulas are one of the most frustrating complications of Crohn’s disease, and for years the only real option was repeated surgery. The introduction of biologic drugs, particularly anti-TNF agents like infliximab and adalimumab, changed that picture. These medications work by dampening the overactive immune response that drives Crohn’s inflammation and, in doing so, allow fistula tracts to quiet down and close. Infliximab remains the best-studied option, with randomized trials showing it significantly improves fistula closure rates compared to placebo.5PubMed Central. Approach to medical therapy in perianal Crohn’s disease
A systematic review and meta-analysis of randomized placebo-controlled trials found that biologic and targeted therapies were associated with roughly 65 percent higher fistula response rates and nearly twice the remission rates compared to placebo during induction treatment lasting 4 to 28 weeks. Infliximab and the newer oral drug upadacitinib both showed significantly better response and remission, while ustekinumab, another biologic, also improved remission rates.6PubMed. Biologics and small molecules for perianal Crohn’s disease: a systematic review and meta-analyses of randomized placebo-controlled trials A separate network meta-analysis confirmed that TNF antagonists as a class outperformed placebo for both fistula response and remission.7Inflammatory Bowel Diseases. Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn’s Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
One important caveat: clinical healing, meaning the external opening stops draining, often happens faster than the internal tract actually resolves. MRI studies have shown that the fistula track can remain inflamed and fluid-filled long after the surface looks healed, and stopping treatment too early risks relapse. Prolonged treatment is often needed to fully resolve the internal tract, but preliminary evidence suggests that once MRI confirms true healing, fistulas tend to stay closed whether or not biologic therapy continues.8American Journal of Gastroenterology. Prospective Evaluation of Anti-Tumor Necrosis Factor Therapy Guided by Magnetic Resonance Imaging for Crohn’s Perineal Fistulas
Antibiotics as a First Step
Before or alongside biologics, antibiotics are often the first medications tried for perianal Crohn’s fistulas. Ciprofloxacin and metronidazole are the two most commonly used. In a small randomized pilot study comparing the two drugs against placebo, ciprofloxacin showed a trend toward better fistula response and remission at 10 weeks, with 30 percent of ciprofloxacin-treated patients achieving remission versus none in the metronidazole group and about 13 percent on placebo. The differences were not statistically significant given the tiny sample size, but ciprofloxacin performed most consistently.9PubMed. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn’s disease: a randomized, double-blind, placebo-controlled pilot study In practice, antibiotics are better understood as a bridge or adjunct rather than a standalone cure. They can reduce drainage and calm infection, but fistulas often flare back once the course ends unless a biologic or other therapy is layered on.
Stem Cell Injections
Injecting stem cells directly into a fistula tract is one of the more promising developments for complex perianal fistulas, including those caused by Crohn’s disease. The idea is that mesenchymal stem cells, usually harvested from fat tissue or bone marrow, can promote tissue repair and suppress local inflammation in ways that encourage the tract to fill in and close. A meta-analysis of clinical trials found an overall healing rate of about 63 percent for stem cell injection therapy in complex perianal fistulas, with similar rates whether the fistula was related to Crohn’s disease or not. Autologous stem cells, meaning those taken from the patient’s own body, performed better than cells from a donor, with healing rates of roughly 69 percent versus 51 percent.10PubMed. The clinical efficacy of stem cell therapy for complex perianal fistulas: a meta-analysis
A more recent systematic review found that mesenchymal stem cell transplantation outperformed conventional treatment for complex perianal fistulas across short-term, long-term, and extended follow-up periods, and that healing tended to be sustained.11PubMed Central. Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials In Europe, an allogeneic stem cell product called darvadstrocel is approved specifically for this use. Availability varies by country, and the cost can be substantial, but for patients with fistulas that have failed other treatments, the evidence is encouraging.
Platelet-Rich Plasma
Platelet-rich plasma, or PRP, is prepared by concentrating the platelets from a patient’s own blood draw and injecting the concentrate into the fistula tract. Platelets carry growth factors that promote tissue repair, and the approach has gained traction as a low-risk option. A meta-analysis covering 14 studies and over 500 patients found an overall cure rate of about 72 percent. When PRP was used alone, the rate was around 62 percent; when combined with other treatments, it climbed to roughly 83 percent.12PubMed. Platelet-rich plasma in the treatment of anal fistula: a systematic review and meta-analysis A second systematic review similarly concluded that autologous PRP was effective and safe for anal fistula healing.13PubMed Central. Efficacy and safety of autologous platelet-rich plasma in anal fistula: a systematic review and meta-analysis
PRP is appealing because it uses the patient’s own blood, carries minimal risk of allergic reaction or infection, and can be performed in a clinic setting. The evidence so far is promising, though much of it comes from relatively small studies, and how best to prepare and deliver the plasma, how many injections to give, and which patients benefit most are still being worked out.
Fibrin Glue and Bioprosthetic Plugs
Two of the longest-standing minimally invasive options for anal fistulas involve filling the tract with a material designed to seal it shut. Fibrin glue, a biological adhesive that mimics the final step of blood clotting, is injected into the cleaned-out fistula tract. A prospective study reported an initial success rate of about 87 percent, but the recurrence rate over time was substantial at around 37 percent, leaving a long-term success rate of about 63 percent.14PubMed Central. Long-term results in the treatment of fistula-in-ano with fibrin glue: a prospective study A systematic review noted that healing rates with fibrin glue tended to be lower than with conventional surgery, but a key advantage was the virtual absence of anal incontinence, a real risk with traditional fistula operations.15PubMed Central. Fibrin glue in the treatment of anal fistula: a systematic review
Bioprosthetic plugs take a different approach. Made from animal-derived collagen, these cone-shaped plugs are inserted into the fistula tract to act as a scaffold for the body’s own tissue to grow into. A study following 135 patients with low trans-sphincteric fistulas over a median of 8 years reported an overall healing rate of 56 percent. The main reasons for failure were the plug working itself out of the tract and early surgical-site infection.16PubMed Central. Long-Term Clinical Results of Use of an Anal Fistula Plug for Treatment of Low Trans-Sphincteric Anal Fistulas A Danish study tracking both major plug brands found an overall success rate of about 39 percent after adjusting for recurrences, lower than the initial healing numbers suggested but still reasonable given that these were complex fistulas where other approaches had already failed.17PubMed Central. Efficacy of Plug Treatment for Complex Anorectal Fistulae: Long-term Danish Results
Both fibrin glue and plugs share an important practical benefit: they preserve the anal sphincter. Because neither technique cuts through muscle, the risk of incontinence is essentially zero. That makes them especially attractive for patients with fistulas that pass through a significant portion of the sphincter, where traditional surgical approaches carry meaningful risk of bowel control problems. If the first attempt fails, either treatment can be repeated without burning bridges for future options.
Endoscopic Clip Closure
For fistulas inside the gastrointestinal tract, particularly those connecting the stomach or esophagus to the skin surface, endoscopic closure with over-the-scope clips has emerged as a viable non-surgical option. These clips are deployed through an endoscope, grasp the tissue around the fistula opening, and compress it shut mechanically. A case series of patients with persistent gastrocutaneous fistulas after feeding-tube removal achieved successful closure in all five patients, with no complications during follow-up.18PubMed Central. Over-the-scope-clip closure of long lasting gastrocutaneous fistula after percutaneous endoscopic gastrostomy tube removal in immunocompromised patients: A single center case series In a larger case series of 101 clip applications, fistula closure was achieved in all three fistula cases treated.19PubMed Central. One hundred and one over-the-scope-clip applications for severe gastrointestinal bleeding, leaks and fistulas
The results are not uniformly perfect. A retrospective study evaluating 30 patients with various gastrointestinal leaks and fistulas found that about 53 percent achieved closure after a single clip deployment. Another 27 percent needed additional endoscopic procedures like stenting or additional clips, and 27 percent eventually required surgery.20Clinical Endoscopy. Over-the-Scope Clip in the Treatment of Gastrointestinal Leaks and Perforations Endoscopic clip closure works best for smaller openings and is most appropriate for internal GI fistulas rather than perianal ones. Still, for the right patient, it can avoid what would otherwise be a major abdominal operation.
Hyperbaric Oxygen Therapy
Hyperbaric oxygen therapy, in which you breathe pure oxygen inside a pressurized chamber, promotes wound healing by increasing oxygen delivery to damaged tissue and stimulating the growth of new blood vessels. The evidence for its use in fistulas is still limited, but what exists is encouraging for certain situations. In a study of patients with non-healing throat-to-skin fistulas after cancer surgery, hyperbaric oxygen combined with local wound care achieved closure in about 88 percent of cases, all in patients who had already failed standard conservative treatment.21PubMed. Hyperbaric oxygen therapy as an alternative to surgery for non-healing pharyngocutaneous fistula
For complex perineal fistulas that have failed multiple prior repairs, hyperbaric oxygen therapy has been associated with lower recurrence rates after subsequent reconstruction and more durable healing.22PubMed. Impact of hyperbaric oxygen therapy on complex perineal fistula healing Hyperbaric oxygen is not a standalone cure in most cases, but as an add-on to other non-surgical treatments or before planned reconstruction, it can tip the odds in favor of lasting closure, especially in tissue that has been damaged by radiation, repeated surgery, or chronic inflammation.
How MRI Guides Non-Surgical Treatment
One of the reasons non-surgical fistula management has improved is better imaging. MRI can look inside a fistula tract and distinguish between a tract that is still filled with fluid, which carries a high risk of relapse, and one that has become dominated by scar tissue, which signals a favorable response to treatment.23PubMed. MRI of Perianal Fistulas: Anatomy, Diagnosis, and Perianal Crohn Disease Treatment Monitoring This distinction matters because the external opening of a fistula can look completely healed while the deeper tract is still actively inflamed. Without MRI, doctors and patients can be falsely reassured.
For patients on biologic therapy for Crohn’s-related fistulas, MRI-guided treatment means continuing medication until the internal tract truly resolves, not just until drainage stops. Studies using serial MRI have shown that track resolution often lags behind clinical improvement by months, and that patients whose MRI eventually shows complete healing are the ones most likely to stay fistula-free long-term.8American Journal of Gastroenterology. Prospective Evaluation of Anti-Tumor Necrosis Factor Therapy Guided by Magnetic Resonance Imaging for Crohn’s Perineal Fistulas If you are being treated non-surgically for a perianal fistula, asking your doctor about follow-up MRI to confirm internal healing is a reasonable step.
Setons, Sitz Baths, and Daily Symptom Management
While waiting for medical therapies to work or for a fistula to close on its own, day-to-day comfort matters. A loose seton, a thin thread or rubber band passed through the fistula tract, is not a cure but a management tool. It keeps the tract open and draining, preventing painful abscesses from forming while definitive treatment takes effect. Despite what you might expect, studies have found that patients with a seton in place report the same quality of life as those without one, and no increase in urgency or incontinence.24PubMed Central. Quality of life with anal fistula The seton’s role is to buy time safely, and many patients manage well with one in place for months during biologic induction.
Sitz baths, soaking the perineal area in warm water for 15 to 20 minutes, are a standard recommendation for keeping the area clean and reducing discomfort. Some practitioners have explored adding plant-derived compounds to the bath. A case report documented a multimodal self-management approach that included sitz baths with neem-leaf solution, dietary fiber optimization, and adequate hydration, resulting in complete resolution of symptoms including itching, abscess formation, and discharge in a patient with recurrent fistula-in-ano.25Journal of International Health Sciences and Management. Breaking the Cycle of Recurrence: An Integrative Approach to Chronic Fistula-in-Ano Management This is a single case rather than a controlled trial, so it is best understood as an illustration of the principle that aggressive local care and lifestyle modification can support healing, not as proof of a specific herbal cure.
Silver Nitrate Irrigation
An uncommon approach that has been studied in small numbers is irrigating a persistent fistula tract with silver nitrate solution, which acts as a chemical cauterant to destroy the lining of the tract and stimulate healing from the inside. In a small study of 18 patients with persistent anal fistulas, about 44 percent achieved complete resolution and another 11 percent showed partial healing. No patients developed incontinence or serious complications.26Journal of Coloproctology. Local irrigation with silver nitrate, a non-surgical approach for persistent anal fistula The approach is inexpensive and minimally invasive, but with a 44 percent failure rate in this small series, it is more a last-resort option than a front-line treatment. It may be worth discussing if you have a persistent but uncomplicated fistula and want to avoid or delay surgery.
Why Non-Surgical Does Not Always Mean Non-Procedural
It is worth being honest about what “without surgery” realistically means. Some of the options discussed here, like stem cell injection, fibrin glue, bioprosthetic plug insertion, and endoscopic clip placement, do involve anesthesia, an operating or endoscopy suite, and a medical team performing a hands-on intervention. They are classified as non-surgical or minimally invasive because they avoid cutting through tissue and muscle in the way a traditional fistulotomy or flap repair does, but they are not the same as taking a pill at home.
The real advantage these approaches share is sphincter preservation. Traditional anal fistula surgery, particularly for complex tracts that pass through the sphincter muscles, carries a genuine risk of weakening bowel control. Every minimally invasive option discussed in this article avoids that risk to varying degrees, which is why they exist and why they continue to be developed despite lower overall success rates than definitive surgical repair. For many patients, the calculus is not “does this have the highest cure rate” but “does this give me a reasonable chance of healing without risking incontinence.” If the first attempt fails, the door to surgery remains open, and the sphincter remains intact.
Matching the Approach to the Fistula
Not all fistulas are the same, and the best non-surgical strategy depends on what you are dealing with. The major distinctions that guide treatment include:
- Cause: Crohn’s-related fistulas respond to biologics and immunosuppressants; post-surgical enterocutaneous fistulas are more about nutrition and time; obstetric or radiation-related fistulas often need tissue-based repair.
- Location: Perianal fistulas have the widest range of non-surgical options. Internal GI fistulas may respond to endoscopic clips. Vesicovaginal fistulas can sometimes close with catheter drainage alone.
- Complexity: A simple, short, low-lying fistula tract responds better to fibrin glue and plugs than a branching, high-riding one that passes through much of the sphincter.
- Output volume: High-output enterocutaneous fistulas need aggressive nutritional support and are less likely to close spontaneously than low-output ones.
- Treatment history: A fistula that has already failed multiple repairs is in a different category than a fresh one. Hyperbaric oxygen and stem cells are often reserved for these refractory cases.
Having a thorough workup, often including MRI and examination under anesthesia, before committing to a treatment strategy is important. A fistula that looks simple on the surface sometimes has hidden branches or an abscess cavity that would undermine non-surgical treatment. The goal is to choose the least invasive approach that gives a realistic chance of success for your specific anatomy and medical situation, not to avoid surgery at all costs if surgery is genuinely the best path forward.